Literature DB >> 11318523

Portal hemodynamics in fulminant hepatic failure as assessed by duplex Doppler ultrasonography.

Y Chawla1, A Sreedharan, R K Dhiman, S Jain, S Suri.   

Abstract

Portal hypertension usually occurs in patients with fulminant hepatic failure (FHF). There is, however, no information on portal venous hemodynamics in patients with FHF. Therefore, we studied the portal venous hemodynamics in patients with FHF using duplex Doppler ultrasonography. We measured the portal vein diameter, flow velocity, and volume flow with duplex Doppler ultrasonography in 29 patients with FHF and 15 patients with uncomplicated acute viral hepatitis. No significant difference was observed in the portal vein parameters in the two groups. Nineteen patients with FHF survived. No difference in portal flow velocity and flow rate was observed between survivors and nonsurvivors. A significantly lower portal flow velocity was observed in nine patients of FHF with ascites compared with those without ascites (12.29+/-2.81 vs 16.26+/-4.87 cm/sec; P < 0.01). Portal hemodynamics do not significantly change in fulminant hepatic failure; therefore, it has no prognostic significance.

Entities:  

Mesh:

Year:  2001        PMID: 11318523     DOI: 10.1023/a:1005634812578

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Portal hypertension in acute liver failure.

Authors:  M Navasa; J C Garcia-Pagán; J Bosch; J R Riera; R Bañares; A Mas; M Bruguera; J Rodés
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

2.  Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers.

Authors:  C Sabbá; G G Weltin; D V Cicchetti; G Ferraioli; K J Taylor; T Nakamura; F Moriyasu; R J Groszmann
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

3.  Influence of the degree of liver failure on portal blood flow in patients with liver cirrhosis.

Authors:  N Ljubicić; M Duvnjak; I Rotkvić; B Kopjar
Journal:  Scand J Gastroenterol       Date:  1990-04       Impact factor: 2.423

4.  Doppler flowmetry and portal hypertension.

Authors:  P Burns; K Taylor; A T Blei
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

5.  Portal hypertension in fulminant viral hepatitis.

Authors:  D Lebrec; O Nouel; J Bernuau; B Rueff; J P Benhamou
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

6.  The renin-angiotensin-aldosterone system in fulminant hepatic failure.

Authors:  M Bernardi; S P Wilkinson; H Wernze; H J Spech; G Müller; L Poston; R Williams
Journal:  Scand J Gastroenterol       Date:  1983-05       Impact factor: 2.423

7.  Portal pressure in patients with exudative ascites in the course of acute hepatitis B.

Authors:  X Calvet; J Bruix; J Bosch; J Rodes
Journal:  Liver       Date:  1991-08

8.  Comparison of pulsed Doppler sonography and angiography in patients with portal hypertension.

Authors:  R C Nelson; K E Lovett; J L Chezmar; J H Moyers; W E Torres; F B Murphy; M E Bernardino
Journal:  AJR Am J Roentgenol       Date:  1987-07       Impact factor: 3.959

9.  Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations.

Authors:  D Valla; J F Flejou; D Lebrec; J Bernuau; B Rueff; J L Salzmann; J P Benhamou
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

10.  Portal blood flow in acute hepatitis with and without ascites: a non-invasive measurement using an ultrasonic Doppler.

Authors:  S S Yang; C H Wu; T K Chen; C L Lee; Y C Lai; D S Chen
Journal:  J Gastroenterol Hepatol       Date:  1995 Jan-Feb       Impact factor: 4.029

View more
  1 in total

1.  Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound.

Authors:  Katsuaki Tanaka; Kazushi Numata; Manabu Morimoto; Kazuhito Shirato; Satoru Saito; Toshio Imada; Shinju Arata; Mitsugi Sugiyama
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.